In a retrospective cohort study including 7,044 patients with T2D, obesity (BMI 27 kg/m 2 ) and HFpEF, combination therapy with an SGLT2i and GLP-1 RA showed a lower risk of HF exacerbation, all-cause emergency department visits and new-onset kidney injury compared with patients only receiving SGLT2i
Recommended for clients with aging skin, sun damage, or pollution-related skin stress
Those with burnout, inflammation, or fat loss goals: Improves recovery
Transporter structural comparisons To further examine the SLC25 proteins most probably relevant to GSH transport, we next conducted structural analyses
Safety, Eligibility, and Who Should Expect Different First-Month Outcomes Semaglutide is not appropriate for everyone
Longitudinal analysis of physical function in older adults: The effects of physical inactivity and exercise training